What is neoplasia what to write in exam about this in 1 and half page

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have more than enough content from Robbins Pathology to write a complete, exam-ready answer. Let me compose it.

NEOPLASIA

Definition

Neoplasia literally means "new growth" (Greek: neo = new, plasia = growth). A neoplasm is an abnormal mass of tissue in which the growth is excessive, uncoordinated, and persists after the removal of the stimulus that initially evoked the change.

The study of tumors is called oncology (Greek: oncos = tumor).

Willis's definition: "A neoplasm is an abnormal mass of tissue, the growth of which exceeds and is uncoordinated with that of normal tissues, and persists in the same excessive manner after cessation of the stimuli which evoked the change."

Components of a Neoplasm

Every tumor, benign or malignant, has two basic components:

Component	Description
Parenchyma	Transformed/neoplastic cells - determines biological behavior and gives the tumor its name
Stroma	Host-derived, non-neoplastic connective tissue, blood vessels, and inflammatory cells - provides structural support and blood supply

Classification: Benign vs. Malignant

Feature	Benign	Malignant
Growth rate	Slow	Rapid
Local invasion	No (expansile, encapsulated)	Yes (infiltrative, no capsule)
Metastasis	No	Yes
Differentiation	Well differentiated	Poorly differentiated / anaplastic
Mitoses	Rare, normal	Frequent, abnormal
Necrosis	Rare	Common
Nuclear changes	Normal	Hyperchromatic, pleomorphic

Nomenclature

Benign tumors: Suffix -oma added to the cell of origin.

Fibroma (fibroblasts), Chondroma (cartilage), Adenoma (epithelial glands), Lipoma (fat)
Papilloma - fingerlike fronds from epithelium
Polyp - projects above mucosal surface

Malignant tumors:

Carcinoma - from epithelial cells (e.g., squamous cell carcinoma, adenocarcinoma)
Sarcoma - from mesenchymal cells (e.g., fibrosarcoma, osteosarcoma, rhabdomyosarcoma)
Blastoma - primitive embryonal tumors (e.g., neuroblastoma, retinoblastoma)

Exceptions (historically misnomered):

Lymphoma, leukemia, melanoma - all malignant despite "-oma" suffix
Teratoma - contains elements of all 3 germ layers

Characteristics of Malignant Tumors

1. Differentiation and Anaplasia

Differentiation = degree to which neoplastic cells resemble their normal counterparts
Anaplasia = lack of differentiation, a hallmark of malignancy
Features of anaplasia:
- Pleomorphism (variation in cell and nuclear size/shape)
- Abnormal nuclear morphology - hyperchromatic, large nuclei, prominent nucleoli
- High nuclear-cytoplasmic ratio (1:1 instead of normal 1:4-6)
- Abundant and abnormal mitoses (tripolar, quadripolar spindles)
- Tumor giant cells
- Loss of polarity

2. Dysplasia

Disordered proliferation short of malignancy
Features: loss of cell uniformity, architectural disorganisation, pleomorphism, hyperchromatic nuclei, abnormal mitoses in upper epithelial layers
Carcinoma in situ - when dysplasia involves the full thickness of epithelium (preinvasive stage)
Mild/moderate dysplasia can regress; severe dysplasia usually progresses

3. Local Invasion

Benign tumors grow as cohesive, expansile masses enclosed in a fibrous capsule
Malignant tumors infiltrate, invade, and destroy surrounding tissue with no capsule
Exception: some well-differentiated cancers may appear encapsulated

4. Metastasis

The most reliable indicator of malignancy. Routes of spread:

Lymphatic spread - more typical of carcinomas; follows regional lymph nodes (e.g., breast cancer to axillary nodes)
Hematogenous spread - favored by sarcomas; tumor cells enter veins (thin-walled), spread to liver and lungs most commonly
Seeding of body cavities - e.g., ovarian carcinoma seeding the peritoneum

Hallmarks of Cancer (Hanahan & Weinberg)

Eight hallmarks + two enabling characteristics:

Self-sufficiency in growth signals - oncogene activation (RAS, MYC)
Insensitivity to growth inhibitory signals - loss of tumor suppressors (RB, TP53)
Evasion of cell death (apoptosis) - BCL-2 overexpression
Limitless replicative potential - telomerase reactivation
Sustained angiogenesis - VEGF upregulation
Invasion and metastasis - matrix metalloproteinase activation
Altered cellular metabolism - Warburg effect (aerobic glycolysis)
Evasion of immune surveillance - PD-L1 expression

Enabling characteristics: Genomic instability and Tumor-promoting inflammation

Epidemiology and Risk Factors

Cancer incidence rises with age (accumulation of somatic mutations + declining immune surveillance)
Environmental factors: smoking (90% of lung cancers), alcohol, diet, radiation, occupational carcinogens
Infectious agents: ~15% of cancers worldwide (HPV, HBV, H. pylori, EBV)
Acquired predisposing conditions: chronic inflammation, immunodeficiency, precursor lesions
Genetic factors: hereditary cancer syndromes (BRCA1/2, APC, RB1, TP53)

Grading and Staging

	Grading	Staging
Based on	Histological differentiation	Clinical/anatomical extent
Method	Microscopy	TNM system (Tumor, Nodes, Metastasis)
Purpose	Predicts aggressiveness	Predicts prognosis, guides treatment
Grade	I (well diff.) to IV (undiff./anaplastic)	Stage I-IV

Summary Comparison Table

Feature	Benign	Malignant
Encapsulation	Present	Absent
Differentiation	Well	Poor/anaplastic
Mitoses	Rare, normal	Frequent, abnormal
Local invasion	No	Yes
Metastasis	Never	Often
Recurrence	Rare	Common
Prognosis	Generally good	Guarded to poor

Source: Robbins & Kumar Basic Pathology, 10th edition, Chapter 6 - Neoplasia

This covers approximately 1.5 pages worth of exam content. Here is a quick guide on what to emphasize based on what examiners typically ask:

Definition (Willis's definition is must-know)
Benign vs. Malignant comparison table (very commonly asked)
Nomenclature with examples and exceptions
Metastasis routes with examples
Hallmarks of cancer (8 hallmarks + 2 enabling features)
Grading vs. Staging distinction
Features of anaplasia - frequently asked as a short note

This is a shared conversation. Sign in to Orris to start your own chat.